News
Updated systemic sclerosis criteria may help in early diagnosis
New classification criteria for systemic sclerosis have just been published and are more sensitive than the 1980 criteria, enabling earlier identification and treatment of this disabling
- Posted by: Dr Rivera
FeatureNews
Fish Oil May Benefit Patients With Early RA
Research published online in Annals of the Rheumatic Diseases suggests that “high-dose fish oil added to a ‘treat to target’ regimen of conventional disease-modifying treatment in early
- Posted by: Dr Rivera
News
New Injectable for Psoriatic Arthritis Approved by the FDA
The US Food and Drug Administration approved Antares Pharma Inc.’s (ATRS) injectable Otrexup, an alternative to pills for hard to treat arthritis and psoriasis cases. Antares Pharma Inc. stated
- Posted by: Dr Rivera
News
Ustekinumab Approved for Psoriatic Arthritis
The FDA has approved ustekinumab (Stelara) alone or in combination with methotrexate for adults with psoriatic arthritis, for the treatment of psoriatic arthritis in adults, according to an
- Posted by: Dr Rivera
News
New Safety Measures
The FDA’s new guidance for extended-release/long-acting opiods will likely impact the use of prescription and over-the-counter non-steroidal anti-inflammatory drugs. The updated indication
- Posted by: Dr Rivera
News
New Safety Measures Announced for Extended-release and Long-acting Opiods
The FDA’s new guidance for extended-release/long-acting opiods will likely impact the use of prescription and over-the-counter non-steroidal anti-inflammatory drugs. The updated indication
- Posted by: Dr Rivera